|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Net loss | |||||
| Add back: Net loss (income) from discontinued operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation, net | |||||
| Bad debt expense | |||||
| Amortization of deferred revenue | |||||
| Depreciation and amortization expense | |||||
| Amortization related to unfavorable solar renewable energy agreements | |||||
| Impairment of goodwill | |||||
| Accretion expense | |||||
| Change in fair value of obligation to issue shares of common stock | |||||
| Change in fair value of interest rate swaps | |||||
| Change in fair value of warrant liabilities | |||||
| Interest income related to SEMTH master lease agreement | |||||
| Gain on extinguishment of debt | |||||
| Gain on disposal of assets | |||||
| Change in operating right-of-use assets and lease liability | |||||
| Amortization of debt discount and deferred financing costs | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Deferred rent assets | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Other long-term liabilities | |||||
| Deferred revenue | |||||
| Net cash used in continuing operating activities | |||||
| Net cash used in discontinued operating activities | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Proceeds from sale of solar energy systems | |||||
| Proceeds from investment related to SEMTH master lease agreement | |||||
| Cash paid for acquisitions | |||||
| Purchases of other property and equipment | |||||
| Net cash used in continuing investing activities | |||||
| Net cash provided by discontinued investing activities | |||||
| Net cash provided by (used in) continuing investing activities | |||||
| Financing activities: | |||||
| Proceeds from issuance of non-recourse debt | |||||
| Payment of deferred financing costs | |||||
| Repayments of non-recourse debt | |||||
| Repayments under financing leases | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from exercise of stock options | |||||
| Share repurchases | |||||
| Capital distributions to noncontrolling interests | |||||
| Buyout of redeemable non-controlling interest | |||||
| Net cash provided by (used in) continuing financing activities | |||||
| Net cash provided by discontinued financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents and restricted cash: | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of noncash investing and financing information: | |||||
| Recording of operating lease asset and liability | |||||
| Right-of-use asset obtained in exchange for lease liability | |||||
| Settlement of operating lease liability | |||||
| Settlement of finance lease liability | |||||
| Settlement of contingent liability through issuance of shares | |||||
Loading...